Skip navigation
Skip navigation

Use of intravitreal rituximab for treatment of vitreoretinal lymphoma

Larkin, Kelly L; Saboo, Ujwala S; Comer, Grant M; Forooghian, Farzin; Mackensen, Friederike; Merrill, Pauline; Sen, H Nida; Singh, Arun; Essex, Rohan; Lake, Stewart; Lim, Lyndell L


Aim: Vitreoretinal lymphoma is a diffuse large B cell non-Hodgkin lymphoma. Targeting malignant cells with rituximab is being used increasingly as local chemotherapy, but information on this treatment is scant. We aimed to describe current therapeutic approaches, as well as responses to and complications of, intravitreal rituximab in patients with vitreoretinal lymphoma. Methods: Clinical data were collected in a standardised manner retrospectively on patients with vitreoretinal lymphoma...[Show more]

CollectionsANU Research Publications
Date published: 2014
Type: Journal article
Source: British Journal of Ophthalmology
DOI: 10.1136/bjophthalmol-2013-304043


File Description SizeFormat Image
01_Larkin_Use_of_intravitreal_rituximab_2014.pdf203.79 kBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  20 July 2017/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator